NOVAVAX INC (NVAX) — insider trading
Health Care · NASDAQ
NOVAVAX INC (NVAX) has 34 reported SEC Form 4 insider transactions in our data (latest 2026-06-20).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-20 | Alton Gregg H | Director | Option exercise / conversion (derivative) | 18,880 | — | $0 | Form 4 |
| 2026-06-20 | Alton Gregg H | Director | Option exercise / conversion | 18,880 | — | — | Form 4 |
| 2026-06-20 | MOTT DAVID M | Director | Option exercise / conversion (derivative) | 18,880 | — | $0 | Form 4 |
| 2026-06-20 | MOTT DAVID M | Director | Option exercise / conversion | 18,880 | — | — | Form 4 |
| 2026-06-20 | MCGLYNN MARGARET G | Director | Option exercise / conversion (derivative) | 18,880 | — | $0 | Form 4 |
| 2026-06-20 | MCGLYNN MARGARET G | Director | Option exercise / conversion | 18,880 | — | — | Form 4 |
| 2026-06-20 | DOUGLAS RICHARD | Director | Option exercise / conversion (derivative) | 18,880 | — | $0 | Form 4 |
| 2026-06-20 | DOUGLAS RICHARD | Director | Option exercise / conversion | 18,880 | — | — | Form 4 |
| 2026-06-20 | King Rachel K. | Director | Option exercise / conversion (derivative) | 18,880 | — | $0 | Form 4 |
| 2026-06-20 | King Rachel K. | Director | Option exercise / conversion | 18,880 | — | — | Form 4 |
| 2026-06-20 | Rodgers Richard J | Director | Option exercise / conversion (derivative) | 18,880 | — | $0 | Form 4 |
| 2026-06-20 | Rodgers Richard J | Director | Option exercise / conversion | 18,880 | — | — | Form 4 |
| 2026-06-18 | Newton Charles W. | Director | Grant / award / vesting (derivative) | 14,180 | — | $0 | Form 4 |
| 2026-06-18 | Newton Charles W. | Director | Grant / award / vesting (derivative) | 21,270 | — | $0 | Form 4 |
| 2026-06-18 | Shiver John W. | Director | Grant / award / vesting (derivative) | 14,180 | — | $0 | Form 4 |
| 2026-06-18 | Shiver John W. | Director | Grant / award / vesting (derivative) | 21,270 | — | $0 | Form 4 |
| 2026-06-18 | Alton Gregg H | Director | Grant / award / vesting (derivative) | 14,180 | — | $0 | Form 4 |
| 2026-06-18 | Alton Gregg H | Director | Grant / award / vesting (derivative) | 21,270 | — | $0 | Form 4 |
| 2026-06-18 | MOTT DAVID M | Director | Grant / award / vesting (derivative) | 14,180 | — | $0 | Form 4 |
| 2026-06-18 | MOTT DAVID M | Director | Grant / award / vesting (derivative) | 21,270 | — | $0 | Form 4 |
| 2026-06-18 | MCGLYNN MARGARET G | Director | Grant / award / vesting (derivative) | 14,180 | — | $0 | Form 4 |
| 2026-06-18 | MCGLYNN MARGARET G | Director | Grant / award / vesting (derivative) | 21,270 | — | $0 | Form 4 |
| 2026-06-18 | DOUGLAS RICHARD | Director | Grant / award / vesting (derivative) | 14,180 | — | $0 | Form 4 |
| 2026-06-18 | DOUGLAS RICHARD | Director | Grant / award / vesting (derivative) | 21,270 | — | $0 | Form 4 |
| 2026-06-18 | King Rachel K. | Director | Grant / award / vesting (derivative) | 14,180 | — | $0 | Form 4 |
| 2026-06-18 | King Rachel K. | Director | Grant / award / vesting (derivative) | 21,270 | — | $0 | Form 4 |
| 2026-06-18 | Rodgers Richard J | Director | Grant / award / vesting (derivative) | 14,180 | — | $0 | Form 4 |
| 2026-06-18 | Rodgers Richard J | Director | Grant / award / vesting (derivative) | 21,270 | — | $0 | Form 4 |
| 2026-04-25 | Newton Charles W. | Director | Option exercise / conversion (derivative) | 9,520 | — | $0 | Form 4 |
| 2026-04-25 | Newton Charles W. | Director | Option exercise / conversion | 9,520 | — | $0 | Form 4 |
| 2026-04-14 | Walker Robert Edward | Officer (EVP, R&D) | Grant / award / vesting (derivative) | 66,000 | — | $0 | Form 4 |
| 2026-04-14 | Walker Robert Edward | Officer (EVP, R&D) | Grant / award / vesting (derivative) | 99,500 | — | $0 | Form 4 |
| 2026-03-10 | Shiver John W. | Director | Option exercise / conversion (derivative) | 7,947 | — | $0 | Form 4 |
| 2026-03-10 | Shiver John W. | Director | Option exercise / conversion | 7,947 | — | $0 | Form 4 |
Ask the chat about NVAX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: NOVAVAX INC (NVAX).
Last updated 2026-06-20 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.